{"task_id": "bb4d25b10b30676b", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 248/464)", "text": " of chemotherapy (in which\nFebrile Neutropenia\n237\n\n--- Page 259 ---\nTREATMENT ISSUES (CONT\u2019D)\nprimary prophylaxis was not received), in which a\nreduced dose may compromise disease free survi\nval overall survival, or treatment outcome\n\u0002\nTREATMENT OF PATIENTS WITH FEBRILE NEUTROPENIA\nGCSF should be given to those with high risk of\ndeveloping complications, including expected pro\nlonged (>10 days) and profound (<0.1\u0005109/L)\nneutropenia, age >65 years, uncontrolled primary\ndisease, pneumonia, hypotension and multi organ\ndysfunction (sepsis), invasive fungal infection, being\nhospitalized at the time of the development of fever\n\u0002\nSPECIAL SITUATIONS\n\u0002\nSTEM CELL TRANSPLANT\nto mobilize peripheral\nblood progenitor cell often in conjunction with\nchemotherapy. Also administered after autolo\ngous, but not allogeneic, stem cell transplantation\n\u0002 DLBCL\nprophylactic GCSF should be given for\npatients with diffuse aggressive lymphoma age\n65 and older treated with curative chemotherapy\n(CHOP or more aggressive regimens)\n\u0002 AML\nmay be given shortly after completion of\nthe initial induction chemotherapy to modestly\ndecrease the duration of neutropenia\n\u0002 ALL\nrecommended after the completion of\nthe initial first few days of chemotherapy of\nthe initial induction or first post remission\ncourse, thus shortening the duration of neutro\npenia by approximately 1 week\n\u0002 MDS\nmay be used to increase the ANC in\nneutropenic patients. Intermittent administra\ntion of CSFs may be considered in a subset of\nTREATMENT ISSUES (CONT\u2019D)\npatients with severe neutropenia and recurrent\ninfections\n\u0002\nPOST-RADIATION\nGCSF\nshould\nbe\ngiven\nto\npatients exposed to lethal doses of total body\nradiotherapy, but not doses high enough to lead\nto certain death due to injury to other organs\nJ Clin Oncol 2006 24:19\nSPECIFIC ENTITIES\nNECROTIZING ENTEROCOLITIS (typhlitis)\n\u0002\nPATHOPHYSIOLOGY\nmucosal injury in patients with\nprofound neutropenia ! impaired host defense\n! necrosis of bowel wall, involving cecum extend\ning into ascending colon and terminal ileum\n\u0002\nCLINICAL\nFEATURES\nabdominal pain (especially\nRLQ) in neutropenic patients\n\u0002\nDIAGNOSIS\nCT abd. Avoid barium enema and\ncolonoscopy\n\u0002\nTREATMENTS\nbowel rest, NG suction, IV fluids, nutri\ntional support, broad spectrum antibiotics (includ\ning metronidazole for C. difficile and amphotericin\nB/fluconazole for fever >72 h), GCSF. Surgical indi\ncations include peritonitis, perforation, persistent GI\nbleeding, or clinical deterioration\nRelated Topics\nChemotherapy (p. 226)\nNeutropenia (p. 148)\nSepsis (p. 97)\nStem Cell Transplant (p. 180)\nFever with Travel History\nNEJM 2002 347:7\nhttp://www.cdc.gov\nDIFFERENTIAL DIAGNOSIS\nFEVER WITH CNS INVOLVEMENT\n\u0002\nBACTERIAL\nmeningococcal, typhoid fever, rick\nettsial, leptospirosis\n\u0002\nMYCOBACTERIAL\ntuberculosis\n\u0002\nVIRAL\nJapanese encephalitis, West Nile encepha\nlitis, tick borne encephalitis, poliomyelitis, rabies\n\u0002\nFUNGAL\ncoccidioidomycosis\n\u0002\nPARASITIC\nmalaria, angiostrongyliasis, trypan\nosomiasis\nFEVER WITH RESPIRATORY INVOLVEMENT\n\u0002\nBACTERIAL\nS. pneumoniae, mycoplasma, Legio\nnella, Q fever, typhoid fever, scrub typhus\n\u0002\nMYCOBACTERIAL\ntuberculosis\n\u0002\nVIRAL\ninfluenza, parainfluenza, metapneumovirus,\nrespiratory syncytial virus, adenovirus, dengue\n\u0002\nFUNGAL\nhistoplasmosis, coccidioidomycosis\nDIFFERENTIAL DIAGNOSIS (CONT\u2019D)\n\u0002\nPARASITIC\nmalaria, Loeffler\u2019s syndrome (migra\ntion of larval helminths such as ascaris, strongy\nloides, and hookworm)\nFEVER WITH RASH\nsee FEVER AND RASH (p. 234)\nHEMORRHAGIC FEVER\n\u0002\nBACTERIAL\nrickettsial, meningococcemia, leptos\npirosis\n\u0002\nVIRAL\ndengue, yellow fever, Ebola fever, Lassa\nfever\n\u0002\nPARASITIC\nmalaria\nFEVER WITH SEXUAL OR BLOOD EXPOSURES\nsyphilis, CMV, EBV, HIV, HBV\nFEVER WITH EOSINOPHILIA\nparasitic (acute\nhookworm, ascaris, strongyloides, acute schistoso\nmiasis, visceral larva migrans, lymphatic filariasis,\nacute trichinosis)\n238\nFever with Travel History", "text_length": 3862, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 248/464)", "type": "chunk", "chunk_index": 247, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.588702", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.589582", "status": "complete", "chunks_added": 2}